Stavros Vlatakis

Mr. Stavros Vlatakis

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
WZWeiqi Zhang
Weiqi Zhang
YSYuhong Shi
Yuhong Shi
SSShazwan Abd Shukor
Shazwan Abd Shukor
AVAaran Vijayakumaran
Aaran Vijayakumaran
SVStavros Vlatakis
Stavros Vlatakis
Maya ThanouMaya Thanou
Maya Thanou
The scheme of loading drugs/decorations in nanodroplets and US/laser irradiated drug release (figure created with BioRender.com).

17 May 2023 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
WZWeiqi Zhang
Weiqi Zhang
HMHildegard Metzger
Hildegard Metzger
SVStavros Vlatakis
Stavros Vlatakis
ACAmelia Claxton
Amelia Claxton
MCM. Alejandra Carbajal
M. Alejandra Carbajal
Maya ThanouMaya Thanou
Maya Thanou
Phase-change nanodroplets have attracted increasing interest in recent years as ultrasound theranostic nanoparticles. They are smaller compared to microbubbles and they may distribute better in tissues (e.g. in tumours). They are composed of a stabilising shell and a perfluorocarbon core. Nanodroplets can vaporise into echogenic microbubbles forming cavitation nuclei when exposed to ultrasound. Their perfluorocarbon core phase-change is responsible for the acoustic droplet vaporisation. However, methods to quantify the perfluorocarbon core in nanodroplets are lacking. This is an important feature that can help explain nanodroplet phase change characteristics. In this study, we fabricated nanodroplets using lipids shell and perfluorocarbons. To assess the amount of perfluorocarbon in the core we used two methods, 19F NMR and FTIR. To assess the cavitation after vaporisation we used an ultrasound transducer (1.1 MHz) and a high-speed camera. The 19F NMR based method showed that the fluorine signal correlated accurately with the perfluorocarbon concentration. Using this correlation, we were able to quantify the perfluorocarbon core of nanodroplets. This method was used to assess the content of the perfluorocarbon of the nanodroplets in solutions over time. It was found that perfluoropentane nanodroplets lost their content faster and at higher ratio compared to perfluorohexane nanodroplets. The high-speed imaging indicates that the nanodroplets generate cavitation comparable to that from commercial contrast agent microbubbles. Nanodroplet characterisation should include perfluorocarbon concentration assessment as critical information for their development.

28 December 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SVStavros Vlatakis
Stavros Vlatakis
WZWeiqi Zhang
Weiqi Zhang
STSarah Thomas
Sarah Thomas
PCPaul Cressey
Paul Cressey
AMAlexandru Corneliu Moldovan
Alexandru Corneliu Moldovan
Maya ThanouMaya Thanou
Maya Thanou
Phase-change nanodroplets (PCND;NDs) are emulsions with a perfluorocarbon (PFC) core that undergo acoustic vaporisation as a response to ultrasound (US). Nanodroplets change to microbubbles and cavitate while under the effect of US. This cavitation can apply forces on cell connections in biological barrier membranes, such as the blood–brain barrier (BBB), and trigger a transient and reversible increased permeability to molecules and matter. This study aims to present the preparation of lipid-based NDs and investigate their effects on the brain endothelial cell barrier in vitro. The NDs were prepared using the thin-film hydration method, followed by the PFC addition. They were characterised for size, cavitation (using a high-speed camera), and PFC encapsulation (using FTIR). The bEnd.3 (mouse brain endothelial) cells were seeded onto transwell inserts. Fluorescein with NDs and/or microbubbles were applied on the bEND3 cells and the effect of US on fluorescein permeability was measured. The Live/Dead assay was used to assess the BBB integrity after the treatments. Size and PFC content analysis indicated that the NDs were stable while stored. High-speed camera imaging confirmed that the NDs cavitate after US exposure of 0.12 MPa. The BBB cell model experiments revealed a 4-fold increase in cell membrane permeation after the combined application of US and NDs. The Live/Dead assay results indicated damage to the BBB membrane integrity, but this damage was less when compared to the one caused by microbubbles. This in vitro study shows that nanodroplets have the potential to cause BBB opening in a similar manner to microbubbles. Both cavitation agents caused damage on the endothelial cells. It appears that NDs cause less cell damage compared to microbubbles.

9 May 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SASahar Awwad
Sahar Awwad
NINkiruka Ibeanu
Nkiruka Ibeanu
TLTianyang Liu
Tianyang Liu
AVAngeliki Velentza-Almpani
Angeliki Velentza-Almpani
NCNerisha Chouhan
Nerisha Chouhan
YBYann Bouremel
Yann Bouremel
Real-time measurement is important in modern dissolution testing to aid in parallel drug characterisation and quality control (QC). The development of a real-time monitoring platform (microfluidic system, a novel eye movement platform with temperature sensors and accelerometers and a concentration probe setup) in conjunction with an in vitro model of the human eye (PK-Eye™) is reported. The importance of surface membrane permeability when modelling the PK-Eye™ was determined with a “pursing model” (a simplified setup of the hyaloid membrane). Parallel microfluidic control of PK-Eye™ models from a single source of pressure was performed with a ratio of 1:6 (pressure source:models) demonstrating scalability and reproducibility of pressure-flow data. Pore size and exposed surface area helped obtain a physiological range of intraocular pressure (IOP) within the models, demonstrating the need to reproduce in vitro dimensions as closely as possible to the real eye. Variation of aqueous humour flow rate throughout the day was demonstrated with a developed circadian rhythm program. Capabilities of different eye movements were programmed and achieved with an in-house eye movement platform. A concentration probe recorded the real-time concentration monitoring of injected albumin-conjugated Alexa Fluor 488 (Alexa albumin), which displayed constant release profiles. These results demonstrate the possibility of real-time monitoring of a pharmaceutical model for preclinical testing of ocular formulations.